A detailed history of Novo Holdings transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Novo Holdings holds 1,100,000 shares of RCKT stock, worth $18.3 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
1,100,000
Previous 1,100,000 -0.0%
Holding current value
$18.3 Million
Previous $23.7 Million 14.21%
% of portfolio
1.42%
Previous 1.69%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$20.66 - $26.72 $1.03 Million - $1.34 Million
50,000 Added 4.76%
1,100,000 $23.7 Million
Q4 2023

Feb 14, 2024

BUY
$16.78 - $31.94 $822,220 - $1.57 Million
49,000 Added 4.9%
1,050,000 $31.5 Million
Q3 2023

Nov 14, 2023

BUY
$15.07 - $24.05 $1.22 Million - $1.95 Million
81,000 Added 8.8%
1,001,000 $20.5 Million
Q1 2023

May 15, 2023

BUY
$15.79 - $22.6 $1.11 Million - $1.58 Million
70,000 Added 8.24%
920,000 $15.8 Million
Q4 2022

Feb 14, 2023

BUY
$15.5 - $22.76 $3.37 Million - $4.94 Million
217,178 Added 34.32%
850,000 $16.6 Million
Q2 2022

Aug 15, 2022

BUY
$7.96 - $16.64 $159,200 - $332,800
20,000 Added 3.26%
632,822 $8.71 Million
Q4 2021

Feb 14, 2022

BUY
$21.52 - $36.02 $1.69 Million - $2.84 Million
78,737 Added 14.74%
612,822 $13.4 Million
Q3 2021

Nov 15, 2021

BUY
$27.42 - $48.97 $14.6 Million - $26.2 Million
534,085 New
534,085 $16 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.26B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.